about
BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapyPrognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up.Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer.The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata.Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).Screening for skin cancer in bank and insurance employees: risk profile and correlation of self and physician's assessment.Determinants of survival in patients with brain metastases from cutaneous melanoma.Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanomaPrognosis of sentinel node staged patients with primary cutaneous melanomaPrognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis.Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumourSerum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy.Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis.Acral lentiginous melanoma - a skin cancer with unfavourable prognostic features. A study of the German Central Malignant Melanoma Registry (CMMR) in 2050 patients.Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany.Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.Melanoma staging: facts and controversies.Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy.Melanoma epidemiology and trends.Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry.Age and gender are significant independent predictors of survival in primary cutaneous melanoma.Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany.Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer.Excision guidelines and follow-up strategies in cutaneous melanoma: Facts and controversies.Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease.Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients.Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP).Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma.Recurrent nodules in a periauricular plaque-type blue nevus with fatal outcome.Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study.Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival.The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.Increased CCL17 serum levels are associated with improved survival in advanced melanoma.Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009.443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011.Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients.Clinical course and prognostic factors of Merkel cell carcinoma of the skin.
P50
Q27852927-9F250776-EDA9-4709-98A0-85D34A35C830Q31150157-871157A5-A11E-436B-AC47-B51CA15EAB43Q31882118-A5294D80-67A2-4E0F-B050-C1B9532246D8Q31928222-5C28E8BA-6C48-47C8-A632-B35B16DFD799Q33378171-A0258148-2EBC-436E-B469-B3AE0EC90E9DQ33456746-90BCC95E-A42B-4A61-857C-BC2B00D34BAAQ33794890-D0411B90-3BBC-4E1C-B4E8-C7785A890E35Q33831923-DAD6FFFE-4942-412B-BE46-3F9E086E829FQ34140267-180EF822-5D07-4A52-833F-94C85704B151Q34702316-A22551AC-EAF1-4FB7-884B-7872008A0FA9Q34762654-DC0EA1BE-11E7-4B46-B6B7-19DF7FF1B660Q34794495-8C36257D-839C-433B-A380-BB7741339398Q35060623-B92DFFC4-1DD4-42A8-9862-D506D9B9ABCFQ36117266-CEB8A91B-812D-4228-A779-06CF6A80C3F9Q38679622-DF2BC286-BDCF-4535-AD83-A94F8D3A4F09Q38795444-714ED991-C033-43DD-90C4-A8DCB497CDD3Q38925194-B5AD0FD6-75B2-4B01-98D8-5781C8010A05Q39207078-3BF69988-EB43-4602-A571-11EC2D83A3A4Q39425191-E0136A49-D9F8-4444-81DB-8F560C6ECE17Q40017236-999EFA35-F173-4F32-ACFA-7C76645F8E1CQ40111444-98C7B1B3-4E46-44E3-BF4C-E85A88087706Q40119372-E8DADF97-B88D-481F-AC7F-6471757713A8Q40681400-4772425E-8969-4CA5-A394-9B60B295B7DBQ42456611-E0D31AB8-E201-43CB-ACA0-CE2E921919EBQ42474601-34780D3A-DE38-4239-A24B-AEA120C512ABQ43028502-C4D974FC-AF23-494A-A601-B5B3FA0E081DQ44187315-7AA395E1-66A3-4B3F-AC59-55D31662E64BQ46038962-8822C17F-2192-4251-9B74-EACCFC8C7890Q50060650-190EBE79-1FC4-415A-AF96-AE2E9F12D990Q50089833-755E86B9-FB29-4957-9517-E4F1F63020D6Q50238463-B76ED012-5A36-4C34-B4A4-9AC81EFF89E6Q50240315-6283622A-FB57-4C30-A4C1-71E0B2BFA2F3Q50522125-84B4C5E1-C6A3-4947-B7CB-C76EC4C70F2AQ50583302-17FB6BD5-5000-4D40-8B70-947D6BBB17E1Q50787155-41068DF7-0972-452B-BDB4-2FD2A307B48BQ51023581-0B822358-071D-4763-B27B-652396E9CD1BQ51038913-D31732E5-E2DA-48AE-976F-AA8AB1D5DA3CQ51041712-31C362F2-4969-43D6-A188-703ADDACE79BQ51468285-0D4765BB-0441-4201-AEC4-4E644B2E11CCQ51639077-01058D41-E4F4-4653-B55A-006DA71F1E9C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ulrike Leiter
@ast
Ulrike Leiter
@en
Ulrike Leiter
@es
Ulrike Leiter
@nl
Ulrike Leiter
@sl
type
label
Ulrike Leiter
@ast
Ulrike Leiter
@en
Ulrike Leiter
@es
Ulrike Leiter
@nl
Ulrike Leiter
@sl
prefLabel
Ulrike Leiter
@ast
Ulrike Leiter
@en
Ulrike Leiter
@es
Ulrike Leiter
@nl
Ulrike Leiter
@sl
P106
P1153
6603673281
P21
P31
P496
0000-0002-8019-1577